Krabeva contains Bevacizumab, 100mg/4mL, 400mg/16mL, supplied as injection (iv). Manufacturer: Hetero Biopharma. Therapeutic class: VEGF mAb Biosimilar.
Prescription-only medicine. Supplied against a named-patient prescription, or to holders of a valid drug import or wholesale licence in the destination country.
For indications, dosing and safety information, refer to the approved product label in the prescriber’s country.